Analysis on status of milk beverage consumption among the population in nine provinces of China

Objective This study aimed to describe the status of milk beverage consumption and the influence factors. Methods This study selected 13 953 samples by stratified multistage cluster random sampling in 2013. The study samples consisted of aged 3 and above with completed three non-consecutive 24 h dietary recalls and food frequency data. A Logistic regression was used to analyze the influence factors. Results The prevalence of milk beverage was 9.7% (1 350/13 953). The drinking frequency was 1.6% (217/13 953), 0.7% (94/13 953) and 7.4% (1 039/13 953) for whom consumed 1 or more times per day, 4 to 6 times per week, and 1 to 3 times per week, respectively. The prevalence was 8.5% (592/6 934) and 10.8% (758/7 019) for male and female, respectively. Stratified by age groups, the prevalence was the highest among 3 to 6-year-olds (35.5%, 165/465) and the lowest among 60 years and above (4.5%, 123/2 740). Urban prevalence (7.7%, 534/6 954) was lower than rural (11.7%, 816/6 999). The per capita consumption of milk beverage was 6.2 mL/d among all the participants (134.4 mL/d among consumers), and was 5.6 mL/d and 6.9 mL/d for male and female, respectively. Stratified by age groups, the consumption was the highest among 3 to 6-year-olds (35.6 mL/d) and the lowest among 60 years and above (2.6 mL/d). The consumption was lower in urban residents (3.2 mL/d) than that of rural residents (9.2 mL/d). Factors associated with the consumption of milk beverage were gender, age, occupation, urban-rural difference and region. Conclusion The prevalence and per capita consumption of milk beverage were relatively low among 3 years or above residents in China. Children and adolescents (3 to 17-year-old) are the main consumers of milk beverage

Analysis on sugar intake from carbonated beverages aged 3 years and above of China

Objective To investigate sugar intake from carbonated beverages of Chinese residents. Methods Multistage stratified random cluster and probability proportionate sampling method was used, and 27 485 residents aged 3 and above were included from one urban and one rural district of 14 provinces (cities) in China. Data was collected by non-continuous 3-day and 24-hour-dietary retrospective method. The added sugar content in 132 carbonated beverages was obtained through the investigation of added sugar content in beverages, the energy provided by added sugar in carbonated beverages was calculated and compared with the total dietary energy from the nutrition and health monitoring diet of Chinese residents, and energy supply ratio of added sugar in carbonated drinks was calculated. Results In 2014, the daily intake of added sugar from carbonated beverages was 0.5 g, and the energy supply ratio was 0.11%. The mean daily intake of added sugar was 13.4 g, the median was 12.3 g, and the energy supply ratio was 2.69%. The median daily intake of carbonated beverages for males (15.3 g) was higher than that for females (10.1 g), it was higher for the urban areas (13.8 g) than that for rural areas (10.7 g), the differences were statistically significant (P0.05). In addition, the consumption of carbonated beverages in urban areas (3.02%) was higher than that in rural areas (2.01%), the difference was statistically significant (P<0.05). The energy supply ratio of carbonated beverage in 13-17 age group was 3.41%. Conclusion Adolescents are the high consumption group of carbonated drinks, so we should strengthen health education to guide reasonable consumption

Mucormycosis: an emerging disease?

ABSTRACTMucormycosis is the third invasive mycosis in order of importance after candidiasis and aspergillosis and is caused by fungi of the class Zygomycetes. The most important species in order of frequency is Rhizopus arrhizus (oryzae). Identification of the agents responsible for mucormycosis is based on macroscopic and microscopic morphological criteria, carbohydrate assimilation and the maximum temperature compatible with its growth. The incidence of mucormycosis is approximately 1.7 cases per 1000 000 inhabitants per year, and the main risk-factors for the development of mucormycosis are ketoacidosis (diabetic or other), iatrogenic immunosuppression, use of corticosteroids or deferoxamine, disruption of mucocutaneous barriers by catheters and other devices, and exposure to bandages contaminated by these fungi. Mucorales invade deep tissues via inhalation of airborne spores, percutaneous inoculation or ingestion. They colonise a high number of patients but do not cause invasion. Mucormycosis most commonly manifests in the sinuses (39%), lungs (24%), skin (19%), brain (9%), and gastrointestinal tract (7%), in the form of disseminated disease (6%), and in other sites (6%). Clinical diagnosis of mucormycosis is difficult, and is often made at a late stage of the disease or post-mortem. Confirmation of the clinical form requires the combination of symptoms compatible with histological invasion of tissues. The probable diagnosis of mucormycosis requires the combination of various clinical data and the isolation in culture of the fungus from clinical samples. Treatment of mucormycosis requires a rapid diagnosis, correction of predisposing factors, surgical resection, debridement and appropriate antifungal therapy. Liposomal amphotericin B is the therapy of choice for this condition. Itraconazole is considered to be inappropriate and there is evidence of its failure in patients suffering from mucormycosis. Voriconazole is not active in vitro against Mucorales, and failed when used in vivo. Posaconazole and ravuconazole have good activity in vitro. The overall rate of mortality of mucormycosis is approximately 40%